Logo image of NBIX

NEUROCRINE BIOSCIENCES INC (NBIX) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:NBIX - US64125C1099 - Common Stock

133.35 USD
-1.98 (-1.46%)
Last: 1/15/2026, 8:00:02 PM
134.14 USD
+0.79 (+0.59%)
After Hours: 1/15/2026, 8:00:02 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
NBIX revenue by date.NBIX revenue by date.
1.489B
31.34%
1.887B
26.76%
2.355B
24.81%
2.913B
23.68%
3.451B
18.47%
3.762B
9.01%
4.154B
10.42%
4.236B
1.97%
4.699B
10.93%
5.206B
10.79%
5.519B
6.01%
5.781B
4.75%
EBITDA
YoY % growth
NBIX ebitda by date.NBIX ebitda by date.
266.3M
21.76%
416.1M
56.25%
610.1M
46.62%
657.81M
7.82%
824.99M
25.41%
1.076B
30.43%
1.314B
22.12%
1.465B
11.49%
1.96B
33.79%
2.739B
39.74%
3.535B
29.06%
3.999B
13.13%
EBIT
YoY % growth
NBIX ebit by date.NBIX ebit by date.
250.7M
20.64%
394.8M
57.48%
583M
47.67%
676.19M
15.98%
943.59M
39.55%
1.172B
24.21%
1.427B
21.76%
1.343B
-5.89%
1.77B
31.79%
2.559B
44.58%
2.745B
7.27%
3.217B
17.19%
Operating Margin
NBIX operating margin by date.NBIX operating margin by date.
16.84%20.92%24.75%23.21%27.34%31.15%34.35%31.70%37.67%49.15%49.74%55.65%
EPS
YoY % growth
NBIX eps by date.NBIX eps by date.
1.53
15.91%
2.42
58.17%
3.29
35.95%
5.13
55.94%
7.20
40.43%
8.64
19.91%
13.84
60.15%
13.46
-2.75%
15.63
16.17%
15.54
-0.61%
16.53
6.37%
17.79
7.63%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
1.94
94.42%
1.48
1,751.07%
1.75
65.25%
1.89
-7.27%
2.04
5.12%
Revenue
Q2Q % growth
821.66M
30.90%
794.07M
38.68%
853.91M
24.21%
891.09M
12.10%
927.66M
12.90%
EBITDA
Q2Q % growth
264.39M
53.63%
207.54M
563.07%
204.9M
27.66%
217.2M
-17.07%
139.63M
-47.19%
EBIT
Q2Q % growth
241.17M
66.32%
181.98M
667.85%
216.86M
48.94%
248.22M
3.73%
291.11M
20.71%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
2.04
64.52%
1.620.4226.10%
Q2 2025
Q2Q % growth
1.06
68.25%
0.990.077.00%
Q1 2025
Q2Q % growth
0.08
-80.95%
0.56-0.48-85.62%
Q4 2024
Q2Q % growth
1.00
-30.56%
1.59-0.59-37.18%
Q3 2024
Q2Q % growth
1.24
51.22%
1.50-0.26-17.35%
Q2 2024
Q2Q % growth
0.63
-33.68%
1.08-0.45-41.42%
Q1 2024
Q2Q % growth
0.42
153.16%
1.03-0.61-59.17%
Q4 2023
Q2Q % growth
1.44
63.64%
1.170.2723.28%
Q3 2023
Q2Q % growth
0.82
18.84%
0.99-0.17-16.79%
Q2 2023
Q2Q % growth
0.95
627.78%
0.790.1619.84%
Q1 2023
Q2Q % growth
-0.79
-664.29%
0.13-0.92-697.25%
Q4 2022
Q2Q % growth
0.88
1,200.00%
1.18-0.30-25.33%
Q3 2022
Q2Q % growth
0.69
7.81%
0.81-0.12-14.90%
Q2 2022
Q2Q % growth
-0.18
-141.86%
0.61-0.79-129.58%
Q1 2022
Q2Q % growth
0.14
-57.58%
0.36-0.22-60.95%
Q4 2021
Q2Q % growth
-0.08
-111.11%
0.53-0.61-115.18%
Q3 2021
Q2Q % growth
0.64
203.23%
0.620.023.97%
Q2 2021
Q2Q % growth
0.43
-46.91%
0.49-0.06-12.38%
Q1 2021
Q2Q % growth
0.33
-15.38%
0.52-0.19-36.84%
Q4 2020
Q2Q % growth
0.72 0.550.1731.63%
Q3 2020
Q2Q % growth
-0.62 0.17-0.79-456.57%
Q2 2020
Q2Q % growth
0.81 0.750.068.08%
Q1 2020
Q2Q % growth
0.39 0.55-0.16-29.31%
NBIX Yearly EPS VS EstimatesNBIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 5 10 15
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
794.9M
27.78%
761.45M33.45M4.39%
Q2 2025
Q2Q % growth
687.5M
16.49%
665.66M21.84M3.28%
Q1 2025
Q2Q % growth
572.6M
11.12%
573.41M-810K-0.14%
Q4 2024
Q2Q % growth
627.7M
21.84%
641.57M-13.87M-2.16%
Q3 2024
Q2Q % growth
622.1M
24.72%
612.64M9.46M1.54%
Q2 2024
Q2Q % growth
590.2M
30.37%
556.86M33.34M5.99%
Q1 2024
Q2Q % growth
515.3M
22.57%
522.21M-6.91M-1.32%
Q4 2023
Q2Q % growth
515.2M
25.05%
528.84M-13.64M-2.58%
Q3 2023
Q2Q % growth
498.8M
28.59%
479.9M18.9M3.94%
Q2 2023
Q2Q % growth
452.7M
19.70%
456.25M-3.55M-0.78%
Q1 2023
Q2Q % growth
420.4M
35.35%
417.45M2.95M0.71%
Q4 2022
Q2Q % growth
412M
32.05%
417.05M-5.05M-1.21%
Q3 2022
Q2Q % growth
387.9M
31.05%
384.51M3.39M0.88%
Q2 2022
Q2Q % growth
378.2M
30.91%
348.13M30.07M8.64%
Q1 2022
Q2Q % growth
310.6M
31.28%
310.27M330K0.11%
Q4 2021
Q2Q % growth
312M
25.86%
323.85M-11.85M-3.66%
Q3 2021
Q2Q % growth
296M
14.51%
303.75M-7.75M-2.55%
Q2 2021
Q2Q % growth
288.9M
-4.46%
279M9.9M3.55%
Q1 2021
Q2Q % growth
236.6M
-0.21%
255.65M-19.05M-7.45%
Q4 2020
Q2Q % growth
247.9M 266.32M-18.42M-6.92%
Q3 2020
Q2Q % growth
258.5M 288.7M-30.2M-10.46%
Q2 2020
Q2Q % growth
302.4M 265.73M36.67M13.80%
Q1 2020
Q2Q % growth
237.1M 228.35M8.75M3.83%
NBIX Yearly Revenue VS EstimatesNBIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B 5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.62% 6.25% -0.17% 13.2%
Revenue0% 2.56% -0.07% 2.39%